发明授权
US07417053B2 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
失效
吡唑并[1,5-a]吡啶衍生物或其药学上可接受的盐
![Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof](/docs/US/2008-08-26/US07417053B2/abs.jpg.600x600.jpg)
- 专利标题： Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
- 专利标题（中）： 吡唑并[1,5-a]吡啶衍生物或其药学上可接受的盐
-
申请号： US11399484申请日： 2006-04-07
-
公开(公告)号： US07417053B2公开(公告)日： 2008-08-26
- 发明人: Gen Unoki , Yoshiyuki Matsumoto , Yohei Matsueda , Tomomi Kosugi , Mika Takakuwa , Hiroaki Makino , Kenichiro Kataoka , Yuko Yamakoshi , Motoko Hamada
- 申请人： Gen Unoki , Yoshiyuki Matsumoto , Yohei Matsueda , Tomomi Kosugi , Mika Takakuwa , Hiroaki Makino , Kenichiro Kataoka , Yuko Yamakoshi , Motoko Hamada
- 申请人地址： JP Tokoyo
- 专利权人： Teijin Pharma Limited
- 当前专利权人： Teijin Pharma Limited
- 当前专利权人地址： JP Tokoyo
- 代理机构： Sughrue Mion, PLLC
- 优先权： JP2005-111419 20050407; JP2005-254677 20050902
- 主分类号： A01N43/42
- IPC分类号： A01N43/42 ; A61K31/44 ; C07D471/02 ; C07D491/02 ; C07D498/02 ; C07D513/02 ; C07D515/02
![Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof](/abs-image/US/2008/08/26/US07417053B2/abs.jpg.150x150.jpg)
摘要：
A pyrazolo[1,5-a]pyridine derivative represented by formula (I) and salt thereof exhibit excellent MAPKAP-K2 inhibitory activity. Accordingly, medicines comprising this compound as an active ingredient are expected to be valuable for treating or preventing diseases mediated by MAPKAP-K2 such as inflammatory injury, autoimmune diseases, asteropathia destruens, cancer and/or growth of tumor.
公开/授权文献
信息查询
IPC分类:
